Ketoconazole in the treatment of pityriasis versicolor: international review of clinical trials.
Multiple open and double-blind studies have confirmed the efficacy of ketoconazole in the treatment of pityriasis versicolor. Single-dose (400 mg) or short-course (200 mg/d for five days) therapy may be highly effective for selected patients with pityriasis versicolor. Toxicity seems to be minimal at this dosage.
Department of Medicine, University of Florida College of Medicine, Gainesville 32610.
D R
DR
Goodless
F A
FA
Ramos-Caro
F P
FP
Flowers
D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects / Q000627:therapeutic use*; D014010:Tinea Versicolor / Q000188:drug therapy*
D007654:Ketoconazole